Science Explorer Interactive view Map

Nektar Therapeutics (United States)

World rank, all time
#17,741
of 42,892
Rank in United States
#3,856
of 8,685
Research works
153
▲ 24% vs 2013–17
Citations
9.7k
63.5 per fractional work
Top-10% rate
11.4%
record average 16.5%
Open access
28%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.35× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 31.33× its world share, 5 worksImmunology and Micro…Neuroscience: 0.24× its world share, 0 worksNeuroscienceChemistry: 0.32× its world share, 0 worksChemistryEngineering: 0.06× its world share, 0 worksEngineeringMaterials Science: 0.19× its world share, 0 worksMaterials ScienceMathematics: 5.66× its world share, 1 worksMathematicsMedicine: 2.30× its world share, 7 worksMedicineDecision Sciences: 1.03× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.78× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 31.3×. Every wedge is a field page.

Who are the top researchers at Nektar Therapeutics (United States)?

Ranked on the composite score, Mary Tagliaferri, Jonathan Zalevsky and Ute Hoch lead among researchers whose main affiliation is Nektar Therapeutics (United States).

  1. 1 Mary Tagliaferri United States · #420,137 worldwide 46 citations · 22 works
  2. 2 Jonathan Zalevsky United States · #520,890 worldwide 57 citations · 20 works
  3. 3 Ute Hoch United States · #1,210,932 worldwide 46 citations · 26 works
All ranked researchers at Nektar Therapeutics (United States)

Which keywords describe research at Nektar Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Nanoparticles, Tumor Microenvironment, Natural Killer Cells, NK Cell Recognition, Tumor Regression and Inhaler Devices.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy17▲ 17×14 topics
  2. Cancer Immunotherapy16▲ 77×2 topics
  3. Nanoparticles16▲ 7.8×10 topics
  4. Tumor Microenvironment13▲ 23×5 topics
  5. NK Cell Recognition11▲ 74×1 topic
  6. Natural Killer Cells11▲ 74×1 topic
  7. Tumor Regression11▲ 85×2 topics
  8. Inhaler Devices11▲ 233×1 topic
  9. Lymphoma11▲ 48×4 topics
  10. Pulmonary Drug Delivery11▲ 233×1 topic
  11. Chemotherapy10▲ 9.6×10 topics
  12. Leukemia10▲ 100×2 topics
  13. CAR T Cells10▲ 148×1 topic
  14. Chimeric Antigen Receptor10▲ 148×1 topic
  15. Immune Checkpoint Blockade10▲ 114×1 topic
  16. PD-1 and PD-L110▲ 114×1 topic
  17. Immunity8▲ 15×5 topics
  18. Dendritic Cells7▲ 38×2 topics
  19. Innate Immunity7▲ 13×2 topics
  20. Antigen Presentation7▲ 43×1 topic
  21. Tumor Antigen7▲ 53×1 topic
  22. Monoclonal Antibodies6▲ 28×3 topics
  23. Biomarkers6▲ 6.4×8 topics
  24. Clinical Trials6▲ 6.2×9 topics
  25. Targeted Therapy6▲ 17×5 topics
  26. Inhibitors5▲ 46×2 topics
  27. Therapeutic Antibodies5▲ 25×2 topics
  28. Genetic Variants5▲ 14×2 topics
  29. DNA4▲ 92×1 topic
  30. Topoisomerases4▲ 92×1 topic
  31. Prognostic Factors4▲ 6.1×7 topics
  32. Biopharmaceuticals4▲ 38×2 topics
  33. Immunogenicity4▲ 50×2 topics
  34. Metastasis4▲ 6.9×3 topics
  35. Cyclodextrins4▲ 99×1 topic
  36. Encapsulation Techniques4▲ 129×1 topic
  37. Solid Dispersions4▲ 99×1 topic
  38. Spray Drying4▲ 129×1 topic
  39. Gene Therapy3▲ 7.5×4 topics
  40. Metastatic Breast Cancer3▲ 30×2 topics

Which research topics does Nektar Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Galectins and Cancer Biology and Cancer Immunotherapy and Biomarkers.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Immune Cell Function and Interaction Immunology 2 works
  3. 3 Galectins and Cancer Biology Immunology 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 T-cell and B-cell Immunology Immunology 1 works
  7. 7 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  8. 8 Dermatology and Skin Diseases Dermatology 0 works
  9. 9 Biosimilars and Bioanalytical Methods Immunology 0 works
  10. 10 Neuroblastoma Research and Treatments Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.8%not open72.2%

World: 28% of research is openly available.

with international co-authors16.3%domestic only83.7%

World: 19% is written across borders.

How has Nektar Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 24% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.